Mobile: +91 992-500-9739

Tele: +91 79 403-07106

Email: info@newedgeoverseas.com

admin

NEWEDGE Overseas > Articles by: admin
Indian pharmaceutical industry

How To Choose The Right CMO And CDMO Partners

In recent years, the Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organization (CDMO) are becoming an integral part of the Indian pharmaceutical industry. Developing and manufacturing a new drug substance is a prolonged process that requires a complex methodology, infrastructure, resources, and a significant investment. Therefore, both CMO and CDMO are feasible alternatives of outsourcing in comparison to in-house manufacturing and development. Many pharmaceutical companies collaborate with CMOs and CDMOs to increase operational efficiencies and reduce costs.

Why is Contract Manufacturing beneficial?

Collaborating with CMO and CDMO gives multiple benefits to pharmaceutical companies in addition to cost-effectiveness. Pharmaceutical companies can utilize their expertise, innovation, and insight to become more successful in the market. In addition, companies get access to their facilities and equipment, add a drug variation, and meet the market demands by improving the scale-up of the business.

Indian pharmaceutical industry

Critical considerations for choosing the right partner for CMO and CDMOs:

Following are a few questions to ask and some factors to consider while choosing a CMO and CDMO partner to make the partnership most beneficial.

  1. Identifying your company’s needs and expectations from the contract company:

    Analysis of the company’s needs is the first step towards selecting a partner. Are you looking for a long-term relationship for the resources or just for one single project? Are you interested in only API manufacturing or clinical trials? Are you seeking a partner for the formulation, manufacturing, and packaging as well? Ask these questions and focus on the strategic partnership with a CMO or CDMO. After that, look for companies that have the experience and technical expertise to meet your needs.

  1. Will this collaboration help to achieve your company’s goals?

    Evaluation of CMO and CDMO should be based on their commitment to client satisfaction and quality. Moreover, check and verify their range of products from API to finished dosages, method development techniques, equipment, staff training, outsourcing services, and commercial-scale production. Finally, the contract company should have the financial stability and flexibility to handle your product growth. If there are any uncertainties with the contract companies, then it may impact the company’s goals.

Indian pharmaceutical industry

  1. Transparency in communication:

    Effective and strong communication is a key to the success of any relationship. Hence, transparency and a clear vision of communication with your CMO or CDMO partner is vital. In addition, it is essential to establish a flow of data between two organizations like the contact person’s details for technical discussions, handling product strategies, handling any deficiencies, etc. Contract companies should also be easily approachable and involve pharmaceutical companies in their step-by-step process.

  1. Is the contract company in compliance with your quality standards?

    Here are some points to look for in the quality and compliance of CMO and CDMO.
  • Check for the robustness of the quality system of the company.
  • Visit the facility and check for any irregularities.
  • Check whether the site is inspected and approved by the requisite agencies.
  • Is the company undergoing regular internal quality audits?
  • Is the company taking care of method transfers, validations, and stability testing?
  • Are adequate documents maintained for quality submissions?
  • Can the company cope up with the constantly changing regulatory environment?
  • Check for their safety and maintenance procedures.

Indian pharmaceutical industry

  1. Working cohesively for the contract agreement:

    The contract agreement should comprise a detailed list of manufacturing, delivery, quality checks, and safety procedures. In addition, both organizations should clearly state in the agreement who is responsible for what.

    Maintaining confidentiality is another important aspect while partnering with contract companies. A confidentiality agreement should also be there. This would preclude using client names or initials, lock information in a secure area, and send the separate client passwords for electronic access to documents for the benefit of both parties.

Conclusion:

In this blog have discussed some parameters for the selection of your CMO and CDMO partner.

We, at NEWEDGE Overseas, are a trusted name for contract development of APIs and products in FDF forms. With a team of experts who manage your project, we ensure that every available resource is leveraged to provide you with the best solutions for contract development.

When it comes to contract manufacturing, we are your trusted collaborators. By leveraging our extensive network of partners, we offer standardized and tailored solutions as per your specific needs and requirements.

Indian pharmaceutical industry

Indian pharmaceutical industry

Pharmaceutical Industry

Effects, Changes, And Outcomes In The Pharmaceutical Industry Due To The Covid19 Pandemic

Covid 19 Pandemic has affected people, communities, businesses, and almost every sector globally including the pharmaceutical industry. Moreover, it continues to impact almost every aspect of daily life across the globe socially, financially, and health-wise. The pharmaceutical sector worldwide is overwhelmed with the repercussions of the Covid 19 Pandemic with both positive and negative outcomes. Here are some significant areas that were affected during the pandemic:

Moving towards Digitalization and Automation

Covid 19 has created significant turbulence for many pharmaceutical companies. As a result, Pharma companies require a change in going forward and need to be wise when it comes to the decisions for the future. One such step would be towards digitization. During uncertain times, adapting to digital transformation is essential. With precise planning, digital transformation helps to improve the productivity of manufacturing and gives financial sustainability.

In addition, swift processing is the main advantage of digital tools and automating manufacturing processes because the machine-driven process uses artificial intelligence and less human involvement. Moreover, companies have adopted remote auditing of contract companies and remote release of products as their new business strategies. Additionally, hiring a skilled workforce is taking place that can program, operate, and generate data from the new automated machinery.

pharmaceutical industry

Effects on the supply chain management

The supply chain is widely affected due to Covid 19 Pandemic. In addition, lockdown in various countries slowed down transport and cargo operations significantly, resulting in delayed raw materials and API availability. Therefore, it is necessary to have a safe supply chain that can provide consistent quality and quick delivery without any intervention. Today, pharmaceutical companies are vigilant and paying close attention to their suppliers, and maintaining constant contact through digital technologies as a learning lesson.

As a result, supply chains are already becoming more diverse to minimize reliance on a single source of raw materials allowing companies to maintain quality, make and track orders, and get support quickly from suppliers, despite social distancing and travel restrictions.

Risk Assessment of Procedures of products as well as personnel

Pharmaceutical companies should consider risk assessment of the current product development procedures and personnel during the pandemic and make their strategies for the safety of each individual. Many companies have already developed and started following standard operating procedures to meet the Covid-19 impact and its challenges.

For example, companies are now focusing more on contactless operations, personal hygiene, social distancing, and taking all necessary precautions to avoid human transmissions at workplaces and manufacturing facilities by keeping in mind the seriousness of virus spread. In addition, companies are even cautious of their partnerships with contract manufacturing companies due to their dependencies.

But more importantly, these organizations are now acutely aware of the unforeseen contingencies that may arise and are better prepared to handle them. These exigencies may pertain to financials, operations, supply chain resilience, or other such factors. Nevertheless, companies have now nurtured a more robust structure to address them.

pharmaceutical industry

The economic slowdown of non-covid drugs

The industry has faced a severe economic downfall, and stocks of many companies are on the verge of collapse due to Covid 19 pandemic. In addition, the companies that are not involved in manufacturing vaccines, personal protective equipment, masks, or building solutions to support remote care delivery are extensively affected.

In addition, several companies face delayed approval of non-covid related pharmaceutical products and delays in reviewing their applications. As a result, many Asian companies are ceasing their operations as they do not possess digital readiness. On the other hand, many new and upcoming industries from countries like India are emerging as the new pharmaceutical hubs. This is due to the readiness and resilience demonstrated by these companies and the rapid evolution of the policy framework that acts as significant support from the government.

Implementing new ways of handling R&D and Clinical trials

The pandemic has changed the approach of many pharmaceutical companies. As a result, several organizations across the globe are working tirelessly to produce the vaccine and drug development for the covid cure. In addition, the pandemic has shown diversification of pharma companies to produce new products with innovations and research with various other medicines that were in progress before the pandemic.

Companies have initiated new ways of carrying out clinical trials safely and effectively by using electronic tools and additional remote medical options in homes to monitor progress. The remote clinical trials allow patients to participate without the concerns of COVID-19 exposure. In addition, nursing care has been provided at home for specific therapies to conduct the necessary physical examinations. They also allow pharmaceutical companies to contact patients directly and explore creative potential stakeholder journeys.

Conclusion:

We have discussed the challenges and moving forwards from the pandemic. One must adapt to the NEW NORMAL in the pharmaceutical industry after considering the above aspects.

Before or after the Covid 19 pandemic, the Pharmaceutical industry continuously operated to save human lives and manufacture medicines for patients’ well-being. But as the pandemic raged, the industry rose to the occasion and contributed significantly towards the control, treatment, and vaccination against the disease.